Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity
Roma Maguire , Morven Miller , Meurig Sage , John Norrie , Lisa McCann , Lesley Taylor , Nora Kearney
{"title":"Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity","authors":"Roma Maguire , Morven Miller , Meurig Sage , John Norrie , Lisa McCann , Lesley Taylor , Nora Kearney","doi":"10.1016/j.cein.2006.08.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Changes in cancer services to out-patient care have resulted in patients spending limited time in hospital. The use of IT within healthcare has seen the development of innovative ways to support patients in the community. This study aimed to test the procedures and technical systems involved in using an advanced symptom management system (ASyMS) in the home monitoring and symptom management of patients receiving chemotherapy.</p></div><div><h3>Patients and methods</h3><p>Ten patients were recruited from two centres in Scotland. Patients in the intervention group used the mobile phone to record and send their symptom reports to their hospital and receive self-care advice, while the control group received standard care. A risk model was developed which alerted health professionals of symptoms that were severe or life threatening. Patient and professional perceptions were evaluated throughout.</p></div><div><h3>Main results</h3><p>Patients believed that the ASyMS system improved the management of their symptoms and felt reassured they were being monitored at home. Health professionals also found the system beneficial in the management of symptoms and the promotion of timely interventions. The full randomised controlled trial is now underway.</p></div><div><h3>Conclusion</h3><p>The ASyMS system has the potential to improve the management of symptoms in patients with cancer receiving chemotherapy.</p></div>","PeriodicalId":87580,"journal":{"name":"Clinical effectiveness in nursing","volume":"9 3","pages":"Pages 202-210"},"PeriodicalIF":0.0000,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cein.2006.08.013","citationCount":"41","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical effectiveness in nursing","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1361900406000483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 41
Abstract
Objectives
Changes in cancer services to out-patient care have resulted in patients spending limited time in hospital. The use of IT within healthcare has seen the development of innovative ways to support patients in the community. This study aimed to test the procedures and technical systems involved in using an advanced symptom management system (ASyMS) in the home monitoring and symptom management of patients receiving chemotherapy.
Patients and methods
Ten patients were recruited from two centres in Scotland. Patients in the intervention group used the mobile phone to record and send their symptom reports to their hospital and receive self-care advice, while the control group received standard care. A risk model was developed which alerted health professionals of symptoms that were severe or life threatening. Patient and professional perceptions were evaluated throughout.
Main results
Patients believed that the ASyMS system improved the management of their symptoms and felt reassured they were being monitored at home. Health professionals also found the system beneficial in the management of symptoms and the promotion of timely interventions. The full randomised controlled trial is now underway.
Conclusion
The ASyMS system has the potential to improve the management of symptoms in patients with cancer receiving chemotherapy.